Iambic Announces Enchant: A Breakthrough Multimodal Transformer Model
Read more
Platform
Pipeline
Partnerships
News & Media
About
Careers
Contact
Contact
Press
back to blog
Entos (now Iambic) Included in Business Insider's List of Most-Promising Healthcare Start-Ups of 2023
Press
This is some text inside of a div block.
July 19, 2023
Media Contacts
Related announcements
View All
View All
January 6, 2025
Iambic Therapeutics Appoints Michael Secora, Ph.D. as Chief Corporate Development Officer and Chief Financial Officer
Read more
January 6, 2025
Iambic Therapeutics Appoints Michael Secora, Ph.D. as Chief Corporate Development Officer and Chief Financial Officer
Read more
December 18, 2024
Iambic Therapeutics to Present at the 43rd Annual JP Morgan Healthcare Conference
Read more
December 18, 2024
Iambic Therapeutics to Present at the 43rd Annual JP Morgan Healthcare Conference
Read more
December 11, 2024
Iambic Therapeutics Announces Appointment of Peter Olson, Ph.D., as Chief Scientific Officer
Read more
December 11, 2024
Iambic Therapeutics Announces Appointment of Peter Olson, Ph.D., as Chief Scientific Officer
Read more